These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 23535103)

  • 1. Successful desensitization protocol for pyridostigmine hypersensitivity in a patient with myasthenia gravis.
    Aung T; Dowden AY
    Ann Allergy Asthma Immunol; 2013 Apr; 110(4):308. PubMed ID: 23535103
    [No Abstract]   [Full Text] [Related]  

  • 2. Benefits from sustained-release pyridostigmine bromide in myasthenia gravis: results of a prospective multicenter open-label trial.
    Sieb JP; Köhler W
    Clin Neurol Neurosurg; 2010 Nov; 112(9):781-4. PubMed ID: 20663605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful desensitization protocol for pyridostigmine in a 12 year old patient with myasthenia gravis.
    Kaplan F; Topal E
    Turk J Pediatr; 2023; 65(2):326-329. PubMed ID: 37114698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pyridostigmine-induced microcephaly.
    Niesen CE; Shah NS
    Neurology; 2000 May; 54(9):1873-4. PubMed ID: 10802806
    [No Abstract]   [Full Text] [Related]  

  • 5. Pyridostigmine-induced dystonic blepharospasm in a patient with ocular myasthenia gravis.
    Voon YC; Yahya WN; Hasan S; Ibrahim NM
    Mov Disord; 2010 Jul; 25(9):1299-300. PubMed ID: 20629121
    [No Abstract]   [Full Text] [Related]  

  • 6. Overlooked myasthenia gravis in an elderly adult.
    Jiang L; Wu W; Guan W; Wu Z; Nie Y
    J Am Geriatr Soc; 2013 May; 61(5):840-1. PubMed ID: 23672558
    [No Abstract]   [Full Text] [Related]  

  • 7. Joint pain and hyperalgesia due to pyridostigmine bromide in a patient with myasthenia gravis.
    Rostedt A; Stålberg E
    Neurology; 2004 Mar; 62(5):835-6. PubMed ID: 15007152
    [No Abstract]   [Full Text] [Related]  

  • 8. Seronegative myasthenia gravis with bladder dysfunction.
    Marouani I; Kraoua I; Benrhouma H; Rebai I; Rouissi A; Koubaa S; Turki I; Dziri C; Gouider-Khouja N
    Rev Neurol (Paris); 2012 Mar; 168(3):299-300. PubMed ID: 22365108
    [No Abstract]   [Full Text] [Related]  

  • 9. Pyridostigmine-Induced Bradycardia in Patient With MuSK-Ab-Positive Myasthenia Gravis and Alopecia Universalis.
    Nazari F; Abdi S
    J Clin Neuromuscul Dis; 2017 Sep; 19(1):49-50. PubMed ID: 28827491
    [No Abstract]   [Full Text] [Related]  

  • 10. Pseudointernuclear ophthalmoplegia as a presenting feature of ocular myasthenia gravis.
    Nijsse B; Bettink MW; Neuteboom RF
    BMJ Case Rep; 2014 Jun; 2014():. PubMed ID: 24928935
    [No Abstract]   [Full Text] [Related]  

  • 11. Prescription profile of pyridostigmine use in a population of patients with myasthenia gravis.
    Machado-Alba JE; Calvo-Torres LF; Gaviria-Mendoza A; Augusto MejíA-Vélez C
    Muscle Nerve; 2017 Dec; 56(6):1041-1046. PubMed ID: 28214292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyridostigmine-induced microcephaly.
    Polizzi A; Ruggieri M; Vincent A
    Neurology; 2001 Jun; 56(11):1606-7. PubMed ID: 11409415
    [No Abstract]   [Full Text] [Related]  

  • 13. Pyridostigmine-induced microcephaly.
    Al-Shekhlee A; Robin N; Kaminski HJ
    Neurology; 2001 Jun; 56(11):1606-7. PubMed ID: 11402134
    [No Abstract]   [Full Text] [Related]  

  • 14. Response of myasthenia gravis to rituximab in a patient with non-Hodgkin lymphoma.
    Gajra A; Vajpayee N; Grethlein SJ
    Am J Hematol; 2004 Oct; 77(2):196-7. PubMed ID: 15389902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapy of myasthenia gravis with cholinesterase inhibitors--principles and pharmacologic monitoring].
    Henze T
    Fortschr Neurol Psychiatr; 1996 Mar; 64(3):110-21. PubMed ID: 8900891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anaphylaxis by pyridostigmine.
    Castellano A; Cabrera M; Robledo T; Martinez-Cócera C; Cimarra M; Llamazares AA; Chamorro M
    Allergy; 1998 Nov; 53(11):1108-9. PubMed ID: 9860251
    [No Abstract]   [Full Text] [Related]  

  • 17. Overactive bladder in patients with myasthenia gravis-A cross-sectional population-based study.
    Donskov AO; Vinge L; Axelsen SM; Andersen H
    Acta Neurol Scand; 2021 Jul; 144(1):76-80. PubMed ID: 33772766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New approaches to the treatment of pemphigus.
    Grando SA
    J Investig Dermatol Symp Proc; 2004 Jan; 9(1):84-91. PubMed ID: 14870992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of pyridostigmine-induced AV block with hyoscyamine in a patient with myasthenia gravis.
    Gehi A; Benatar M; Langberg J
    J Cardiovasc Electrophysiol; 2008 Feb; 19(2):214-6. PubMed ID: 17711430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticholinesterase abuse in myasthenia gravis.
    Munsat TL
    J Neurol Sci; 1984 Apr; 64(1):5-10. PubMed ID: 6376715
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.